The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients
ConclusionsA formally complete diagnosis according to 2016 CNS WHO was achieved in the majority of cases. The biopsy cohort showed a prognostically unfavorable distribution of diagnoses and molecular features. Frameless stereotactic biopsy seems to be confirmed as a useful diagnostic tool in contemporary neuro-oncology —however, certain potential limitations should be considered.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Astrocytoma | Brain | Brain Tumor | Cancer & Oncology | Glioma | International Medicine & Public Health | Neurology | Study | WHO